FPS-ZM1, a highly potent RAGE inhibitor, can penetrate the blood–brain barrier and has shown therapeutic potential in Alzheimer’s disease and Parkinson’s disease [6–8]. This evidence concerns the gene AGER and Alzheimer disease.